Report Scope:
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.
Report Includes:
- 27 data tables and 50 additional tables
- An overview of the global market for nanomaterials in personalized medicine
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussions of the current and future market potential, and quantification of the market by product type and region
- Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
- Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
- Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
- Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
- Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
- Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
- Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma
Summary:
The field of personalized medicine has entered a new, revolutionary frontier with nanomaterials, which is transforming healthcare at the molecular level. These minute marvels, created with accuracy and cleverness, hold the key to a new era of personalized therapies and diagnostics, ushering in a day when medicine is as distinctive as the person it treats. Nanomaterials represent the pinnacle of innovation in the search for personalized healthcare solutions, opening up countless opportunities to improve patient care and transform the field of medicine.
The increasing prevalence of chronic diseases is boosting the already growing demand for global nanomaterials in the personalized medicine market. Chronic disease affects hundreds of million patients globally. Approximately 45% of Americans, or 133 million people, suffer from one or more chronic healthcare conditions. Similarly, in Europe, nearly 60 million people have more than one chronic disease. Chronic disease prevalence is expected to rise rapidly in the forecast period (2023-2028), and this is expected to create a significant burden on global healthcare.
Similarly, inorganic strategies amongst market players are also boosting the global market for nanomaterials in personalized medicine. For instance, in June 2023, Merck, often known as MSD outside of North America and Canada, acquired Prometheus Biosciences Inc., a biotechnology business in the clinical stages that is leading the way in precision medicine by finding, creating and commercializing innovative therapeutic and companion diagnostic solutions to treat immune-mediated disorders. The Prometheus purchase strengthens Merck's pipeline; this will expand its immunology presence and enhance its capacity to provide patient value. This acquisition will support Merck to change how patients with immune-mediated disorders are treated thanks to the possible best-in-class candidate that Prometheus brings to the table.
The other vital driving factors are rising cancer cases globally, increasing number of diabetes cases worldwide, rising worldwide cases of hypercholesterolemia, and cross-industry collaborations and mergers; these are anticipated to increase the demand for nanomaterials in personalized medicine during the forecast period. However, challenges in nanomaterials in personalized medicine will likely impede market growth during the forecast period.
Major players in the nanomaterials in personalized medicine markets include Bristol-Myers Squibb Co., Eisai Co. Ltd., Gilead Sciences, Ipsen SA, and many others. All the major and emerging players are offering potential personalized nanomedicine for various therapeutic areas.
The global market for nanomaterials in personalized medicine was valued at $REDACTED billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion in 2028. The growth of the global market is attributed to factors such as the rising prevalence of chronic diseases globally, rising cancer cases globally, increasing number of diabetes cases worldwide, and rising worldwide cases of hypercholesterolemia.
Nanomaterials in Personalized Medicine: Global Markets
Table of Contents
Chapter 1 Introduction
Overview of Nanotheranostics
Polymeric Nanomaterials
Magnetic Nanomaterials
Silica-Based Nanomaterials
Carbon Nanomaterials
Composite Nanomaterials
Biologic Nanomaterials: Antibody, Proteins and DNA
Carbon Nanotubes
Other Nanomaterials
Multifunctional Nanomaterials
Drug Delivery
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Insights
Chapter 3 Market Overview
Market Overview
Theranostics and Personalized Medicines Overview
Nanoparticles
Passive Targeting
Active Targeting
Nanotechnology Overview
Size Definition
Shape
Surface Area
Nanotheranostic Drug Delivery
In Vivo Drug-Release Studies
Drug Efficacy
Future Perspectives
Chapter 4 Nanodevices and Nanomaterials in Diagnostics
Overview
Molecular Recognition in Diagnosis
Nanopatterned Devices
Particles
Carbon Nanotubes
Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
Cancer Photothermal Therapy
Carbon Nanotubes for Other Therapeutic Applications
Fullerene C60
C60 Toxicity
Uptake and Biodistribution
Antioxidant Properties
Endohedrals
Magnetic Resonance Imaging
Radionuclides
Photodynamic Therapy
DNA Photocleavage
Cancer
Enzymes, Viruses, and Bacteria Inhibition
Drug and Gene Delivery
Magnetic Nanoparticles
Hyperthermia
Magnetic Separation
Imaging and Delivery
Brain Tumor Delivery
Prostate Cancer
Bladder Tumors
Quantum Dots
Aptamer-Conjugated Nanoparticles
Nanoparticle-Based Bio-Bar Codes
Multiplex Dendrimers
Surface Enhanced Raman Spectroscopy
Diagnostic and Medical Device Industry
Multifunctional Nanoparticles
Polymeric Nanoparticles in Cancer Therapy
Polymeric-Based Imaging Probes for Cancer Imaging
Quantum Dots in Cancer Imaging and Therapy
Quantum Dots in Photodynamic Therapy and Imaging
Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
Gold Nanoparticles for Photothermal Therapy
Gold Nanoshells
Gold Nanorods
Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
Conclusion and Future Trends
Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices
Infections Associated with Medical Devices and Their Treatments
Catheter-Associated Infections
Soft-Tissue-Implant-Associated Infections
Biofilm Formation
Common Methods for Preventing and Treating Medical Device-Associated Infections
Nanomaterials in Medical Applications
Nanomaterials in Personalized Medicine
Antimicrobial Nanomaterials
Silver Nanoparticles
Zinc Oxide
Iron and Iron-Oxide Nanoparticles
Titanium Oxide
Carbon Nanotubes and Fullerenes
Chitosan
Cytotoxicity Consideration
Chapter 6 Biomedical Nanoparticle Products
Introduction
Contract Manufacturing Organizations
Information Technology
Nanoparticle Drug Delivery Systems and Products
Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
Chapter 7 Therapeutic and Diagnostic Companion Kits
Introduction
Chapter 8 Market Dynamics
Market Drivers
Rising Prevalence of Chronic Diseases Globally
Rising Cancer Cases Globally
Cancer Mortality
Increasing Number of Diabetes Cases Worldwide
Rising Worldwide Cases of Hypercholesterolemia
Other major drivers in the personalized medicine market are:
Market Restraints
Challenges with Personalized Medicine
Market Opportunities
Nanodrug Delivery for the Treatment of Neurological Disorders
Increasing Government Investment in Healthcare Sectors
Rising Healthcare Costs
Consumer Expectations
Chapter 9 Regulatory Landscape
Overview
Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
Regulatory Issues in Nanotechnology
Nanomedicines in the Pharmaceutical Market
Market Access and Pharmacoeconomics
Chapter 10 Impact of COVID-19 on the Market
Overview
Structure of COVID-19 and Penetration
COVID-19 Crisis
Impact of COVID-19 on Nanomaterials in Personalized Medicine
Novel Coronavirus Relying on Various Approaches
Challenges in Vaccine Disruptions
Components and Methods in the Design of a Vaccine
Antigens
Adjuvants
Nanoparticles/Nanocarriers
Devices
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusions Regarding Use of Nanotechnology to Combat COVID-19
COVID-19 Measures
Chapter 11 Market Breakdown by Product Type
Market Overview
Proteins
Monoclonal Antibodies (mAbs)
Monoclonal Antibody Therapy
Mechanism
Nanocrystals
Nanocrystals Fabrication
Liposomes
Liposome Classification and Preparation
Sonication
Extrusion
Freeze-Thawed Liposomes
Solvent Dispersion Method
Detergent-Removal Method
Stealth Liposome
Antibody-Liposome Conjugate
Liposome Application in Medicine and Pharmacology
Liposomes in Parasite Diseases and Infections
Liposomes in Anticancer Therapies
In Vitro Optical Imaging
Gold Nanocarrier
Hyperthermia
Contrast Enhancers
Radiotherapy
Quantum Dots as Nanocarriers
Photophysical Properties, Drug-Delivery and Drug-Release Sensing
Visualizing Intracellular Uptake In Vitro
Nanocarrier Biodistribution In Vivo
Short Interfering RNA and DNA delivery
Chapter 12 Market Breakdown by Region
Overview
North America
U.S. Market Size and Forecast
Canada Market Size and Forecast
Europe
Germany Market Size and Forecast
U.K. Market Size and Forecast
France Market Size and Forecast
Italy Market Size and Forecast
Spain Market Size and Forecast
Rest of European Market Size and Forecast
Asia-Pacific
China Market Size and Forecast
Japan Market Size and Forecast
India Market Size and Forecast
South Korea Market Size and Forecast
Rest of Asia-Pacific Market Size and Forecast
Rest of the World
South America Market Size and Forecast
Middle East and Africa Market Size and Forecast
Chapter 13 ESG Development
Introduction to ESG
Environmental
Social
Government
The Sustainability of Major Companies in the Industry
Pharma End User Sustainability in the Industry
Case Study
Concluding Remarks from BCC
Chapter 14 Emerging Technologies
Overview
Current Market Trends
Emerging Technologies
Biomarkers
Deep Phenotyping Technologies
Digital Precision Medicine
Genetics
Health Information Technology
Chapter 15 Patents and Pipeline Analysis
Overview
Patent Analysis
Pipeline Analysis
Chapter 16 M&A Outlook
M&A Analysis
Major Strategic Alliances
Chapter 17 Competitive Landscape
Overview
Distribution of Nanobiotechnology and Nanomedicine Companies
Company Share Analysis
Chapter 18 Company Profiles
BRISTOL-MYERS SQUIBB
CAMURUS AB
CYTIMMUNE SCIENCES
EISAI
GILEAD SCIENCES INC.
IPSEN PHARMA
Chapter 19 Appendix: Acronyms
List of Tables
Summary Table : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table A : Types of Nanomaterials
Table B : Major Nanomaterial Applications in Personalized Medicine
Table 1 : Therapies with Diagnostic Companion Kits
Table 2 : Nanoparticle Systems Approved for Drug Delivery
Table 3 : Imaging Modalities Used in Theranostics Nanodevices
Table 4 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 5 : Major Players in Nanoparticle Drug Development and Formulation Market
Table 6 : Nanoparticles Used in Drug Delivery Systems
Table 7 : List of Marketed Products Used in Different Nanotechnology-Based Techniques
Table 8 : Major Companies in the Market for Nanoparticle Drug Development and Formulation
Table 9 : Company Pipelines for Cardiovascular Nanoparticle Drugs
Table 10 : Company Pipelines for CNS Disease Nanoparticle Drugs
Table 11 : Company Pipelines for GI Disease Nanoparticle Drugs
Table 12 : Company Pipelines for Infectious Disease Nanoparticle Drugs
Table 13 : Company Pipelines for Cancer Nanoparticle Drugs
Table 14 : Company Pipelines for Ophthalmic Nanoparticle Drugs
Table 15 : Company Pipelines for Autoimmune Disease Nanoparticle Drugs
Table 16 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
Table 17 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
Table 18 : Global Deaths, by Various Cancer Types, Through 2030
Table 19 : Global Death Share, by Various Cancer Types, 2021
Table 20 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 21 : Cases of Diabetes Worldwide, by Type, 2019
Table 22 : Global Prevalence of Diabetes, by Type, Through 2040
Table 23 : Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
Table 24 : Global Incidence and Prevalence of all Stroke Types, 2019
Table 25 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 26 : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table 27 : Products of Non-monoclonal Antibody Proteins
Table 28 : Global Market for Proteins in Personalized Medicine, by Region, Through 2028
Table 29 : Major Companies in the Market for Monoclonal Antibodies
Table 30 : Indications of Monoclonal Antibody Products
Table 31 : Global Market for Monoclonal Antibodies in Personalized Medicine, by Region, Through 2028
Table 32 : Properties of Nanocrystals
Table 33 : Nanocrystal Drug Features
Table 34 : Nanocrystal Fabrication Methods
Table 35 : Nanocrystal Drugs Currently on the Market
Table 36 : Global Market for Nanocrystals in Personalized Medicine, by Region, Through 2028
Table 37 : Liposome Advantages
Table 38 : Liposome-Based Drugs
Table 39 : Major Companies in the Liposomes Market
Table 40 : Global Market for Liposomes in Personalized Medicine, by Region, Through 2028
Table 41 : Global Market for Gold Nanoparticles in Personalized Medicine, Through 2028
Table 42 : Global Market for Quantum Dots in Personalized Medicine, Through 2028
Table 43 : Global Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 44 : Diabetes Estimates in North America, by Country, 2000-2045
Table 45 : Influenza Disease Burden in U.S., by Age Group, 2019 and 2020 Influenza Season
Table 46 : North America Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 47 : Diabetes Estimates in Europe, by Country, 2000-2045
Table 48 : European Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 49 : Tuberculosis Burden of Asian Countries, by Country, 2019
Table 50 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 51 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 52 : Diabetes Estimates in the RoW, by Country, 2000-2045
Table 53 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 54 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 55 : Key Focus Areas in ESG Metrics
Table 56 : ESG Rankings for Select Nanomaterials Personalized Medicine Companies, 2023
Table 57 : Examples of Nanomaterials Used in Theranostics
Table 58 : Global Patents on Nanotechnologies, by Country, 2017-2020
Table 59 : Number of Patents, by Technology, 2001-2021*
Table 60 : Protein Drugs
Table 61 : Nanoparticle Systems Approved for Drug Delivery
Table 62 : Major Strategic Alliances, 2018-2023
Table 63 : Major Players in the Nanoparticles Drug Field
Table 64 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
Table 65 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Table 66 : Bristol-Myers Squibb: Key Developments, 2019
Table 67 : Camurus AB: Financial Performance, 2021 and 2022
Table 68 : Camurus AB: Key Developments, 2019
Table 69 : Cytimmune Sciences: News, 2021
Table 70 : Eisai: Financial Performance, 2021 and 2022
Table 71 : Eisai: News, 2021
Table 72 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Table 73 : Ipsen Pharma: Financial performance, 2021 and 2022
Table 74 : Acronyms Used in This Report
List of Figures
Figure A : Types of Nanomedicine Composed of Different Types of Materials
Summary Figure : Global Market Shares of Nanomaterials in Personalized Medicine, by Product Type, 2022
Figure 1 : Types of Nanomedicines Composed of Different Types of Materials
Figure 2 : Nanoparticles Used in Personalized Medicine
Figure 3 : Nanotechnology Used in Personalized Medicine
Figure 4 : Shares of New Cancer Cases, Women, 2020
Figure 5 : Shares of New Cancer Cases, Men, 2020
Figure 6 : Global Prevalence of Breast Cancer, by Country/Region, 2015-2025
Figure 7 : Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
Figure 8 : Global Deaths, by Various Cancer Types, 2000-2030
Figure 9 : Global Death Share, by Various Cancer Types, 2021
Figure 10 : Cases of Diabetes Worldwide, by Type, 2019
Figure 11 : Global Prevalence of Diabetes, by Type, 2018 and 2040
Figure 12 : Protein Nanoparticle Fabrication and Performance Factors
Figure 13 : Global Market for Proteins in Personalized Medicine, 2020-2028
Figure 14 : Global Market for Monoclonal Antibodies in Personalized Medicine, 2020-2028
Figure 15 : Global Market for Nanocrystals in Personalized Medicine, 2020-2028
Figure 16 : Application of Liposomes in the Drug Delivery Arena
Figure 17 : Global Market for Liposomes in Personalized Medicine, 2020-2028
Figure 18 : Global Market for Gold Nanoparticles in Personalized Medicine, 2020-2028
Figure 19 : Global Market for Quantum Dots in Personalized Medicine, 2020-2028
Figure 20 : Global Market Shares of Nanomaterials in Personalized Medicine, by Region, 2022
Figure 21 : North America Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
Figure 22 : Cancer Diagnosis Share in Europe, by Gender, 2020
Figure 23 : European Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
Figure 24 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, 2020-2028
Figure 25 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, 2020-2028
Figure 26 : How a Strong ESG Proposition Benefits Businesses
Figure 27 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 28 : The Ten Business Sustainability Trends Identified for 2022
Figure 29 : Key Sustainable Practices Being Implemented in Research Laboratories
Figure 30 : Emerging Technologies in the Nanomaterials in Personalized Medicine Market
Figure 31 : Global Market Shares of Nanoparticles in Personalized Medicine, by Company, 2022
Figure 32 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Figure 33 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2022
Figure 34 : Camurus AB: Financial Performance, 2021 and 2022
Figure 35 : Camurus AB: Revenue Share, by Country/Region, 2022
Figure 36 : Eisai: Financial Performance, 2021 and 2022
Figure 37 : Eisai: Revenue Share, by Country/Region, 2022
Figure 38 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Figure 39 : Gilead Sciences Inc.: Revenue Share, by Country/Region, 2022
Figure 40 : Ipsen Pharma: Financial Performance, 2021 and 2022
Figure 41 : Ipsen Pharma: Revenue Share, by Segment, 2022
Figure 42 : Ipsen Pharma: Revenue Share, by Country/Region, 2022
Global Nanopharmaceuticals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 153
According to our LPI (LP Information) latest study, the global Nanopharmaceuticals market size was valued at US$ 30290 million in 2023. With growing demand in downstream market, the Nanopharmaceuticals is forecast to a readjusted size of US$ 73420 million by 2030 with a CAGR of 13.5% during review period.
The research report highlights the growth potential of the global Nanopharmaceuticals market. Nanopharmaceuticals are expected to show stable growth in the future market. However, produ......
Global Nanomedicine Market Research Report 2023
Published: 14-Dec-2023 Price: US 2900 Onwards Pages: 87
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanomedicine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Combimatrix
- Ablynx
- Abraxis Bioscience
- Celgene
- Mallinckrodt
- Arrowhead Research
- GE Healthcare
- Merck
- Pfizer
- Na......
Global Nanomedicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 116
Market Overview of Global Nanomedicine market:
According to our latest research, the global Nanomedicine market looks promising in the next 5 years. As of 2022, the global Nanomedicine market was estimated at USD 181.26 million, and it's anticipated to reach USD 263.67 million in 2028, with a CAGR of 6.45% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nanomedicine market, with......
Nanomaterials in Personalized Medicine: Global Markets
Published: 20-Oct-2023 Price: US 5500 Onwards Pages: 226
Report Scope:
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competiti......
2023-2031 Report on Global Nanopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
Published: 09-Oct-2023 Price: US 2500 Onwards Pages: 122
This report studies the Nanopharmaceuticals market, covering market size for segment by type (Liposomes, Polymeric Micelles, etc.), by application (Cancer and Tumor, Autoimmune Disorders, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Na......
Global Cancer Nanomedicine Market Insights, Forecast to 2029
Published: 20-Sep-2023 Price: US 4900 Onwards Pages: 111
Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the mar......
Asia-Pacific Nanotechnology In Energy Applications Market Forecast 2023-2032
Published: 18-Aug-2023 Price: US 1600 Onwards Pages: 175
KEY FINDINGS
The Asia-Pacific nanotechnology in energy applications market is projected to grow with a CAGR of 13.24% during the forecasting years of 2023-2032. The regional market's growth is ascribed to the gradual improvement of the nanotechnology profile in scientific research, supportive government policies and regulations aimed at promoting renewable energy as well as reducing carbon footprint, and rising concerns associated with greenhouse emissions and safety.
......
Europe Nanotechnology In Energy Applications Market Forecast 2023-2032
Published: 18-Aug-2023 Price: US 1600 Onwards Pages: 165
KEY FINDINGS
The Europe nanotechnology in energy applications market is set to grow with a CAGR of 12.89% over the forecast period of 2023-2032. The regional market's growth is accredited to the European Union's (EU) significant role in promoting nanotechnology in the energy sector as well as the efforts directed toward the transition to a low-carbon economy and minimizing greenhouse gas emissions.
MARKET INSIGHTS
The United Kingdom, Italy, Spain, Pol......
North America Nanotechnology In Energy Applications Market Forecast 2023-2032
Published: 18-Aug-2023 Price: US 1600 Onwards Pages: 168
KEY FINDINGS
The North America nanotechnology in energy applications market is estimated to record a CAGR of 13.01% over the forecast period of 2023-2032. The market growth of the region is augmented by increasing customer demand for high-performance, longer-lasting products, the introduction of new standards and technologies, as well as evolving regulatory requirements.
MARKET INSIGHTS
Canada and the United States are evaluated for the North America ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
